Robert W. Duggan, a Director and 10% Owner of Pulse Biosciences, Inc. (PLSE), made a significant purchase of 660,233 shares on May 11, 2026. The transaction, valued at approximately $13 million, was executed at an average price of $19.69 per share.
This substantial acquisition by Mr. Duggan represents a notable investment in the company's stock. Large insider purchases are often interpreted by the market as a strong signal of an insider's confidence in the company's future performance and prospects.
The recent trading activity in PLSE also includes a purchase of 15,000 shares by Paul A. Laviolette on the same day. However, other transactions from February show Kevin Patrick Danahy selling a total of 45,000 shares across three separate transactions.